Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease - Wikidata - wikimedia - TriplyDB

Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease

Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease

http://www.wikidata.org/entity/Q36995833

about

Calcium and ROS: A mutual interplay Redox signaling, Nox5 and vascular remodeling in hypertension Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering Nox family NADPH oxidases in mechano-transduction: mechanisms and consequences Targeting NADPH oxidases in vascular pharmacology Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system Reactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical Indications NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?The role of oxidative stress and autophagy in atherosclerosis Cross talk between mitochondria and NADPH oxidases Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling Reactive oxygen species in inflammation and tissue injury Unique role of NADPH oxidase 5 in oxidative stress in human renal proximal tubule cells Oxidative risk for atherothrombotic cardiovascular disease.Expression and distribution of NADPH oxidase isoforms in human myometrium--role in angiotensin II-induced hypertrophy.NADPH oxidases in vascular pathology.NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy.Nox5 and the regulation of cellular function.Cardiac Cell Senescence and Redox Signaling.NADPH oxidases: functions and pathologies in the vasculature.Calcium/calmodulin-dependent kinase II mediates the phosphorylation and activation of NADPH oxidase 5.C/EBP transcription factors regulate NADPH oxidase in human aortic smooth muscle cells.Upregulation of intermediate-conductance Ca2+-activated K+ channels (KCNN4) in porcine coronary smooth muscle requires NADPH oxidase 5 (NOX5).Caveolin-1 is a negative regulator of NADPH oxidase-derived reactive oxygen species.Molecular regulation of NADPH oxidase 5 via the MAPK pathway.Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells.Regulation of NADPH oxidase 5 by protein kinase C isoforms.NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies.Impact of Nox5 polymorphisms on basal and stimulus-dependent ROS generation.NOX1, 2, 4, 5: counting out oxidative stress.Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets Expression and functional significance of NADPH oxidase 5 (Nox5) and its splice variants in human blood vessels.The 1027th target candidate in stroke: Will NADPH oxidase hold up?DNA hypermethylation of the NOX5 gene in fetal ventricular septal defect.Epithelial nitration by a peroxidase/NOX5 system mediates mosquito antiplasmodial immunity.Diacerein inhibits the pro-atherogenic & pro-inflammatory effects of IL-1 on human keratinocytes & endothelial cells.Increased epidermal growth factor-like ligands are associated with elevated vascular nicotinamide adenine dinucleotide phosphate oxidase in a primate model of atherosclerosis.Prolonged exposure to methylglyoxal causes disruption of vascular KATP channel by mRNA instability Enzymatic regulation and functional relevance of NOX5 VPO1 mediates ApoE oxidation and impairs the clearance of plasma lipids.

P2860

Q26795721-34DF7A1A-0B64-4A5B-8633-45C3AEFA5B3D Q26801400-ACD9F85D-304C-42C6-9FF6-D1C041DDB583 Q26853120-132C706D-DF02-4AC6-A117-C427F9FD3237 Q26861569-C285A6CA-73EE-4FB0-9F1D-FFD460EB5D68 Q26863500-572997FF-0F64-4734-BDF0-271033429DBB Q26991619-2BF0DD9A-C8F4-4296-A970-72D11FC27A25 Q27024762-94587277-47E9-4FCB-B968-D0F53A3B30C1 Q28072348-794DE001-A519-4C9D-BEF5-AB25ADCDC6AB Q28085161-186D8426-FAE9-482B-89EE-F9B712218739 Q28391403-BC436CB0-8F8E-457E-9CE1-0E6C2D7D2591 Q28393242-CCCD3DA1-E736-48CA-8CE9-B93ECCF6CDE5 Q28396273-BD0F9A18-1CE1-4DD7-A0F4-33E7C5150F89 Q30414139-BD0E823E-09E7-4706-910C-9FD762C5837D Q33554184-4587F110-BFF7-4769-A800-7DA546840705 Q33601928-EFCC03CC-EDF2-4605-B906-BE5A22429B75 Q33632089-DFD5C3C5-167A-414F-9BF4-F4B1C80CF87A Q33632781-F4EAA8DC-E8EC-4959-B02F-4F39623908C4 Q33649858-AADCC8BC-BCBF-4E06-8734-22FA470EB148 Q33734782-2350B232-EDA1-4806-86BF-1236BE546939 Q33739287-DF8A5625-E518-4B9E-B354-5E32317DCFC9 Q33923188-A491E1A1-86D4-48A8-9374-875CAE845810 Q34011539-CD432D59-3776-4C0D-B64C-2829DC0F4E0A Q34075544-52B203D6-4CEB-40E1-B86E-F6A39CC7149A Q34495667-4752070D-B4C9-43C0-A33C-2D215EAE4674 Q34784390-0A85B6DA-4E17-4CAA-9702-28BE0491909D Q35059397-15A4C2D6-6F4F-422C-BF33-6B8330F41C7B Q35088727-470C2740-2868-44CB-A2D3-00F9094ED745 Q35145985-07CA98C0-D4DB-4F17-93FC-8018FC41655B Q35200898-B6DE0914-2CCF-40A5-9AD2-4741E4F3D62A Q35375986-36737B31-E5E5-4CDC-AAB7-EC5CD843F201 Q35992729-06628735-C76D-4640-B1FD-15DE1B639D96 Q35994159-2E5B42CF-63BB-44B0-B3E5-4AD2BAC13F62 Q36112519-552F1E27-5488-41AC-8E26-931314E585EF Q36230847-315480D3-BE47-408A-B136-DA57DCA615FF Q36239698-D44904AB-D762-464B-A2E3-5A3EA63F646E Q36316432-FCB8AA3E-0659-4536-A891-E799D82CAEC1 Q36319377-CFE38FED-4CB7-41A3-9BF1-892C3C881B3D Q36382451-A1983408-1E4D-4ED5-8709-E25A6076E55E Q36574640-4147B8E7-FB25-4BDB-A904-20A7119562F0 Q36636155-F683F94F-B181-416A-9D61-64A808EEF2DB

P2860

Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease

http://www.wikidata.org/entity/Q36995833

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Calcium-dependent NOX5 nicotin ...... human coronary artery disease

@en

type

label

Calcium-dependent NOX5 nicotin ...... human coronary artery disease

@en

prefLabel

Calcium-dependent NOX5 nicotin ...... human coronary artery disease

@en

P1433

Q36995833-3123FF84-207F-42D6-9B18-DA6315880E8D

P1476

Q36995833-68308780-84A1-4E76-84C4-3E4C38FA293A

P2093

Q36995833-0781392C-A81C-43D1-9559-168189EE8D90

Q36995833-0BEA9B00-3CBA-4B16-9A80-073F0D2DB014

Q36995833-45BB8FE2-99C6-4544-941E-DAB284D70AA2

Q36995833-63A6A94D-42BF-4FFD-9F79-1825BA7DA055

Q36995833-93D6DB2F-7935-44A9-A1B8-F14F018E41F9

Q36995833-9B3A7D47-32D0-40B9-A407-647C610324DC

Q36995833-C32B7D0E-B210-47EB-9075-D83975E87167

Q36995833-C7F4F772-7BE6-47CB-923A-7349728242FC

Q36995833-CEDB8F73-7FB7-49A6-8FDE-C9F872404E50

Q36995833-E2633CFF-A047-4A16-A180-E1E8DFAAF16F

P2860

Q36995833-00E9254B-9CD4-44D2-A46B-1B4DB35952FE

Q36995833-0CB4FFC6-B87C-49E3-BAC2-7E67C3FC8071

Q36995833-17C7B202-8DB5-42B4-A839-2FE3371F2951

Q36995833-5D1E3313-740B-413B-BFE5-F5F7B1A225F3

Q36995833-803A02F5-4990-43EC-8020-DB17A102E75E

Q36995833-877DA08B-C61E-4D12-B9E5-148EE09A5875

Q36995833-8E585AE5-98D0-459F-964C-EFD5E5E5916A

Q36995833-99FEC338-153B-42BD-A643-2611AF3FC43A

Q36995833-9CEA897D-DCE7-4699-90B8-6B304F9B3C07

Q36995833-9E689051-A765-4F77-9E61-EFFFD06A324B

P304

Q36995833-26D1232A-FB4D-4763-A35A-E6E3F71C85FD

P31

Q36995833-C3CCC51D-0C63-4A1B-8CAB-DC9AD89531EF

P356

Q36995833-47DA856B-0115-4B6D-B79F-9C5D90C3D501

P407

Q36995833-B2DA6C65-AA79-4605-A3E9-F472890DE1D7

P433

Q36995833-61C301E4-387A-4671-B107-F2EFF8B8C80A

P478

Q36995833-B5CDB29B-D316-46DB-B556-D3200E977696

P577

Q36995833-B3CBAD1C-BD44-4ABE-A56E-964C57C65F49

P5875

Q36995833-4EFD9D6C-7289-4B7D-A1FB-B96FE860C8B1

P698

Q36995833-1086230B-9ED1-4610-B06A-B5FACD46E708

P932

Q36995833-6143EDCB-D530-43AB-8461-550CBD6C65F2

P356

J.JACC.2008.07.063

P1433

Journal of the American College of Cardiology

P1476

Calcium-dependent NOX5 nicotin ...... human coronary artery disease

@en

P2093

Bartlomiej Guzik

http://www.w3.org/2001/XMLSchema#string

Boguslaw Kapelak

http://www.w3.org/2001/XMLSchema#string

David G Harrison

http://www.w3.org/2001/XMLSchema#string

Deepa Mangalat

http://www.w3.org/2001/XMLSchema#string

Heinrich E Lob

http://www.w3.org/2001/XMLSchema#string

Jerzy Sadowski

http://www.w3.org/2001/XMLSchema#string

Maria C Gongora

http://www.w3.org/2001/XMLSchema#string

Nyssa Hoch

http://www.w3.org/2001/XMLSchema#string

Pawel Rudzinski

http://www.w3.org/2001/XMLSchema#string

Sergey Dikalov

http://www.w3.org/2001/XMLSchema#string

P2860

A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes

NOX5 variants are functionally active in endothelial cells

Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels

Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases

Nitric oxide is a physiological substrate for mammalian peroxidases

Atherosclerosis. the road ahead

Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins.

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.

Novel mechanism of activation of NADPH oxidase 5. calcium sensitization via phosphorylation.

Nox regulation of smooth muscle contraction.

P304

1803-1809

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2008.07.063

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23486193

http://www.w3.org/2001/XMLSchema#string

P698

19022160

http://www.w3.org/2001/XMLSchema#string

P932

2593790

http://www.w3.org/2001/XMLSchema#string